Literature DB >> 30293488

Anti-NMDA receptor encephalitis presenting as isolated aphasia in an adult.

Vasilios C Constantinides1, Dimitrios S Kasselimis1,2, George P Paraskevas1, Maria Zacharopoulou1, Elisabeth Andreadou1, Maria-Eleftheria Evangelopoulos1, Elisabeth Kapaki1, Costas Kilidireas1, Eleftherios Stamboulis1, Constantin Potagas1.   

Abstract

Anti-NMDA receptor (NMDA-r) encephalitis is a relatively rare cause of autoimmune encephalitis with divergent clinical presentations. We report a case of an adult patient with anti-NMDA-r encephalitis presenting with isolated, abrupt-onset aphasia. Her condition remained unaltered over a period of 6 months. The patients' electroencephalogram findings were typical for NMDA-r encephalitis; however, her magnetic resonance imaging and cerebrospinal fluid analysis were normal. She responded well to immunotherapy, and aphasia eventually resolved. The natural course of the present case contradicts the rapidly progressive nature of typical NMDA-r encephalitis. Furthermore, it broadens the clinical spectrum of anti-NMDA-r encephalitis, to incorporate isolated, nonprogressive aphasia.

Entities:  

Keywords:  Anti-NMDA-r encephalitis; aphasia; cognitive decline; immunotherapy; language

Mesh:

Year:  2018        PMID: 30293488     DOI: 10.1080/13554794.2018.1524915

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  2 in total

1.  Gerstmann's Syndrome in a Patient Double-positive for Antibodies against the N-methyl-D-aspartate Receptor and NH2-terminal of α-enolase.

Authors:  Atsuhiko Sugiyama; Masahide Suzuki; Tomoki Suichi; Tomohiko Uchida; Takahiro Iizuka; Keiko Tanaka; Makoto Yoneda; Satoshi Kuwabara
Journal:  Intern Med       Date:  2020-11-23       Impact factor: 1.271

2.  Paroxysmal speech disorder as the initial symptom in a young adult with anti-N-methyl-D-aspartate receptor encephalitis: A case report.

Authors:  Chuan-Chen Hu; Xiao-Ling Pan; Mei-Xia Zhang; Hong-Fang Chen
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.